Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Vaccines, Drug Discovery, Translational Science

Backwards Vax Moves Forward

Researchers at the University of Buffalo, New York, have developed an unconventional vaccination approach to help manage the symptoms of chronic and autoimmune conditions. The technique, known as reverse vaccination, trains the immune system to ignore foreign substances rather than attack them.

Where traditional vaccination teaches the immune system to react to  foreign invaders, the team’s antidrug antibody approach builds immune tolerance in patients by pairing enzymes and essential proteins with Lyso-PS, a fatty acid that increases the immune system’s tolerance of foreign substances. The researchers claim that this method can be used to train the body not to attack.

The treatment shows promise in both intravenous and oral formats, which the team believes could boost patient compliance.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Angus Stewart

Angus is Associate Editor of The Medicine Maker

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register